[HTML][HTML] Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets
…, P Vijayakumar, C Odio, J Fournier, S Bermejo… - Nature …, 2020 - nature.com
The recent spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exemplifies
the critical need for accurate and rapid diagnostic assays to prompt clinical and public …
the critical need for accurate and rapid diagnostic assays to prompt clinical and public …
[HTML][HTML] Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2
…, P Wong, Y Yang, S Bermejo… - … England Journal of …, 2020 - Mass Medical Soc
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 | NEJM Skip to main
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …
[PDF][PDF] SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
…, A Casanovas-Massana, J Fournier, S Bermejo… - Med, 2021 - cell.com
Background Scaling SARS-CoV-2 testing to meet demands of safe reopenings continues to
be plagued by assay costs and supply chain shortages. In response, we developed …
be plagued by assay costs and supply chain shortages. In response, we developed …
Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs
Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing
COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR …
COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR …
[PDF][PDF] Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface
…, KH Campbell, A Casanovas-Massana, S Bermejo… - Med, 2021 - cell.com
Background Pregnant women are at increased risk for severe outcomes from coronavirus
disease 2019 (COVID-19), but the pathophysiology underlying this increased morbidity and its …
disease 2019 (COVID-19), but the pathophysiology underlying this increased morbidity and its …
[HTML][HTML] Cutting edge: severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome, resulting in dysregulation of eicosanoid immune mediators
…, L Sharma, L Roberts, X Peng, S Bermejo… - The Journal of …, 2021 - journals.aai.org
The COVID-19 pandemic has affected more than 20 million people worldwide, with mortality
exceeding 800,000 patients. Risk factors associated with severe disease and mortality …
exceeding 800,000 patients. Risk factors associated with severe disease and mortality …
[HTML][HTML] Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19
…, C Castaldi, P Wong, J Fournier, S Bermejo… - Nature …, 2022 - nature.com
Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe
COVID-19. However, the immune signatures associated with immunopathology are poorly …
COVID-19. However, the immune signatures associated with immunopathology are poorly …
[HTML][HTML] Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
…, C Odio, P Vijayakumar, B Geng, J Fournier, S Bermejo… - BMC neurology, 2020 - Springer
Background COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2.
It is widely recognized as a respiratory pathogen, but neurologic complications can be …
It is widely recognized as a respiratory pathogen, but neurologic complications can be …
Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR assays
…, B Geng, P Vijayakumar, C Odio, J Fournier, S Bermejo… - MedRxiv, 2020 - medrxiv.org
The recent spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exemplifies
the critical need for accurate and rapid diagnostic assays to prompt clinical and public …
the critical need for accurate and rapid diagnostic assays to prompt clinical and public …
[HTML][HTML] Stability of SARS-CoV-2 RNA in nonsupplemented saliva
…, A Nelson, J Fournier, S Bermejo… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
The expense of saliva collection devices designed to stabilize severe acute respiratory
syndrome coronavirus 2 RNA is prohibitive to mass testing. However, virus RNA in …
syndrome coronavirus 2 RNA is prohibitive to mass testing. However, virus RNA in …
